Below The Knee Stenosis Comprehensive Study by Type (Balloon Dilation Catheter, Dual Wire Systems, Drug Eluting Stent), Application (Hospital, Ambulatory Surgical Center), End User (Pediatric, Adult, Geriatric) Players and Region - Global Market Outlook to 2027

Below The Knee Stenosis Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Below The Knee Stenosis
Atherosclerosis is an artery condition affected by an accumulation of plaque in the blood that is made up of fat, cholesterol, calcium, and other substances; the plaque narrows the artery over time. Patients can experience artery narrowing in the thigh or below the knee. Most serious type of peripheral artery disease is critical limb ischemia (CLI). The occurrence of chronic ischemic rest pain, ulceration, or gangrene caused by occlusion of peripheral arterial vessels determines it. While revascularization is the first-line therapy, traditional therapies are ineffective in a number of difficult situations. The use of unconventional approaches to treat complex below-the-knee arterial disease is discussed. In addition, the state-of-the-art of gene and cell therapy for the care of patients with no other options is discussed.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Below The Knee Stenosis market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Boston Scientific Corporation (United States), Koninklijke Philips N.V. (Netherlands), Medtronic plc (United States), Shockwave Medical, Inc. (United States), Becton, Dickinson and Company (United States), OrbusNeich Medical (Hong Kong), Orchestra BioMed, Inc. (United States), Rex Medical, L.P. (United States), Bbraun (United Kingdom) and Rontis Corporation AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Meditek Systems (India), Hexacath (France), Vissco Rehabilitation Aids Pvt. Ltd. (India) and Essex Cardiology Group (United States).

Segmentation Overview
AMA Research has segmented the market of Global Below The Knee Stenosis market by Type (Balloon Dilation Catheter, Dual Wire Systems and Drug Eluting Stent), Application (Hospital and Ambulatory Surgical Center) and Region.



On the basis of geography, the market of Below The Knee Stenosis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Pediatric will boost the Below The Knee Stenosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 27th August, 2020 - Philips Completed its acquisition of Intact Vascular (Leading Invasive Peripheral Vascular Product Manufacturer), this Acquisition is Aimed to Expand Philips’ Image-Guided Therapy Devices Portfolio Across Below the Knee Stenosis.
On 22nd April, 2018 – Shockwave Launched its Intravascular Lithotripsy BTK Catheter in European Region which was Recently Received CE Mark Approval. This New Offering Is A Low-Profile Catheter Specifically Designed to Access Calcified Lesions in Below-The-Knee (BTK) Arteries Frequently Associated with Critical Limb Ischemia (CLI).
United States, Food and Drug Admiration “Paclitaxel-Coated Drug Coated Balloon and Drug-Eluting Stent Late Mortality Panel” - Provides Information Regarding the Disease Condition and Currently Marketed Devices Used for Treatment of Below the Knee Stenosis. Any New Device or Manufacturer is Required to have a FDA Approval.

Market Drivers
  • Prevalence of Vascular Disorders
  • Rising Healthcare Awareness
  • Growth in Healthcare and Pharma Infrastructure

Opportunities
  • Low Penetration in Emerging Regions Particularly Asia

Restraints
  • Lack of Trained Professionals

Challenges
  • Regional Regulatory Approval
  • Fierce Competitive Pressure


Key Target Audience
Below the Knee Stenosis Products Manufactures, New Entrants and Investors, Below the Knee Stenosis Products Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Balloon Dilation Catheter
  • Dual Wire Systems
  • Drug Eluting Stent
By Application
  • Hospital
  • Ambulatory Surgical Center
By End User
  • Pediatric
  • Adult
  • Geriatric

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Vascular Disorders
      • 3.2.2. Rising Healthcare Awareness
      • 3.2.3. Growth in Healthcare and Pharma Infrastructure
    • 3.3. Market Challenges
      • 3.3.1. Regional Regulatory Approval
      • 3.3.2. Fierce Competitive Pressure
    • 3.4. Market Trends
      • 3.4.1. Increasing R&D on in Healthcare industry
      • 3.4.2. Rising Geriatric Population
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Below The Knee Stenosis, by Type, Application, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Below The Knee Stenosis (Value)
      • 5.2.1. Global Below The Knee Stenosis by: Type (Value)
        • 5.2.1.1. Balloon Dilation Catheter
        • 5.2.1.2. Dual Wire Systems
        • 5.2.1.3. Drug Eluting Stent
      • 5.2.2. Global Below The Knee Stenosis by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Ambulatory Surgical Center
      • 5.2.3. Global Below The Knee Stenosis by: End User (Value)
        • 5.2.3.1. Pediatric
        • 5.2.3.2. Adult
        • 5.2.3.3. Geriatric
      • 5.2.4. Global Below The Knee Stenosis Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Below The Knee Stenosis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Koninklijke Philips N.V. (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic plc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Shockwave Medical, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. OrbusNeich Medical (Hong Kong)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Orchestra BioMed, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Rex Medical, L.P. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bbraun (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Rontis Corporation AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Below The Knee Stenosis Sale, by Type, Application, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Below The Knee Stenosis (Value)
      • 7.2.1. Global Below The Knee Stenosis by: Type (Value)
        • 7.2.1.1. Balloon Dilation Catheter
        • 7.2.1.2. Dual Wire Systems
        • 7.2.1.3. Drug Eluting Stent
      • 7.2.2. Global Below The Knee Stenosis by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Ambulatory Surgical Center
      • 7.2.3. Global Below The Knee Stenosis by: End User (Value)
        • 7.2.3.1. Pediatric
        • 7.2.3.2. Adult
        • 7.2.3.3. Geriatric
      • 7.2.4. Global Below The Knee Stenosis Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Below The Knee Stenosis: by Type(USD Million)
  • Table 2. Below The Knee Stenosis Balloon Dilation Catheter , by Region USD Million (2016-2021)
  • Table 3. Below The Knee Stenosis Dual Wire Systems , by Region USD Million (2016-2021)
  • Table 4. Below The Knee Stenosis Drug Eluting Stent , by Region USD Million (2016-2021)
  • Table 5. Below The Knee Stenosis: by Application(USD Million)
  • Table 6. Below The Knee Stenosis Hospital , by Region USD Million (2016-2021)
  • Table 7. Below The Knee Stenosis Ambulatory Surgical Center , by Region USD Million (2016-2021)
  • Table 8. Below The Knee Stenosis: by End User(USD Million)
  • Table 9. Below The Knee Stenosis Pediatric , by Region USD Million (2016-2021)
  • Table 10. Below The Knee Stenosis Adult , by Region USD Million (2016-2021)
  • Table 11. Below The Knee Stenosis Geriatric , by Region USD Million (2016-2021)
  • Table 12. South America Below The Knee Stenosis, by Country USD Million (2016-2021)
  • Table 13. South America Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 14. South America Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 15. South America Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 16. Brazil Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 17. Brazil Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 18. Brazil Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 19. Argentina Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 20. Argentina Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 21. Argentina Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 22. Rest of South America Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 23. Rest of South America Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 24. Rest of South America Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 25. Asia Pacific Below The Knee Stenosis, by Country USD Million (2016-2021)
  • Table 26. Asia Pacific Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 27. Asia Pacific Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 28. Asia Pacific Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 29. China Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 30. China Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 31. China Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 32. Japan Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 33. Japan Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 34. Japan Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 35. India Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 36. India Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 37. India Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 38. South Korea Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 39. South Korea Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 40. South Korea Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 41. Taiwan Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 42. Taiwan Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 43. Taiwan Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 44. Australia Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 45. Australia Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 46. Australia Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 50. Europe Below The Knee Stenosis, by Country USD Million (2016-2021)
  • Table 51. Europe Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 52. Europe Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 53. Europe Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 54. Germany Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 55. Germany Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 56. Germany Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 57. France Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 58. France Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 59. France Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 60. Italy Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 61. Italy Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 62. Italy Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 63. United Kingdom Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 64. United Kingdom Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 65. United Kingdom Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 66. Netherlands Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 67. Netherlands Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 68. Netherlands Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 69. Rest of Europe Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 70. Rest of Europe Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 71. Rest of Europe Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 72. MEA Below The Knee Stenosis, by Country USD Million (2016-2021)
  • Table 73. MEA Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 74. MEA Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 75. MEA Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 76. Middle East Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 77. Middle East Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 78. Middle East Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 79. Africa Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 80. Africa Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 81. Africa Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 82. North America Below The Knee Stenosis, by Country USD Million (2016-2021)
  • Table 83. North America Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 84. North America Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 85. North America Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 86. United States Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 87. United States Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 88. United States Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 89. Canada Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 90. Canada Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 91. Canada Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 92. Mexico Below The Knee Stenosis, by Type USD Million (2016-2021)
  • Table 93. Mexico Below The Knee Stenosis, by Application USD Million (2016-2021)
  • Table 94. Mexico Below The Knee Stenosis, by End User USD Million (2016-2021)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Below The Knee Stenosis: by Type(USD Million)
  • Table 106. Below The Knee Stenosis Balloon Dilation Catheter , by Region USD Million (2022-2027)
  • Table 107. Below The Knee Stenosis Dual Wire Systems , by Region USD Million (2022-2027)
  • Table 108. Below The Knee Stenosis Drug Eluting Stent , by Region USD Million (2022-2027)
  • Table 109. Below The Knee Stenosis: by Application(USD Million)
  • Table 110. Below The Knee Stenosis Hospital , by Region USD Million (2022-2027)
  • Table 111. Below The Knee Stenosis Ambulatory Surgical Center , by Region USD Million (2022-2027)
  • Table 112. Below The Knee Stenosis: by End User(USD Million)
  • Table 113. Below The Knee Stenosis Pediatric , by Region USD Million (2022-2027)
  • Table 114. Below The Knee Stenosis Adult , by Region USD Million (2022-2027)
  • Table 115. Below The Knee Stenosis Geriatric , by Region USD Million (2022-2027)
  • Table 116. South America Below The Knee Stenosis, by Country USD Million (2022-2027)
  • Table 117. South America Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 118. South America Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 119. South America Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 120. Brazil Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 121. Brazil Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 122. Brazil Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 123. Argentina Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 124. Argentina Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 125. Argentina Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 126. Rest of South America Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 127. Rest of South America Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 128. Rest of South America Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 129. Asia Pacific Below The Knee Stenosis, by Country USD Million (2022-2027)
  • Table 130. Asia Pacific Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 131. Asia Pacific Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 132. Asia Pacific Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 133. China Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 134. China Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 135. China Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 136. Japan Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 137. Japan Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 138. Japan Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 139. India Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 140. India Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 141. India Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 142. South Korea Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 143. South Korea Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 144. South Korea Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 145. Taiwan Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 146. Taiwan Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 147. Taiwan Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 148. Australia Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 149. Australia Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 150. Australia Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 154. Europe Below The Knee Stenosis, by Country USD Million (2022-2027)
  • Table 155. Europe Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 156. Europe Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 157. Europe Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 158. Germany Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 159. Germany Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 160. Germany Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 161. France Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 162. France Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 163. France Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 164. Italy Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 165. Italy Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 166. Italy Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 167. United Kingdom Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 168. United Kingdom Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 169. United Kingdom Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 170. Netherlands Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 171. Netherlands Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 172. Netherlands Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 173. Rest of Europe Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 174. Rest of Europe Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 175. Rest of Europe Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 176. MEA Below The Knee Stenosis, by Country USD Million (2022-2027)
  • Table 177. MEA Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 178. MEA Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 179. MEA Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 180. Middle East Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 181. Middle East Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 182. Middle East Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 183. Africa Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 184. Africa Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 185. Africa Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 186. North America Below The Knee Stenosis, by Country USD Million (2022-2027)
  • Table 187. North America Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 188. North America Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 189. North America Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 190. United States Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 191. United States Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 192. United States Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 193. Canada Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 194. Canada Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 195. Canada Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 196. Mexico Below The Knee Stenosis, by Type USD Million (2022-2027)
  • Table 197. Mexico Below The Knee Stenosis, by Application USD Million (2022-2027)
  • Table 198. Mexico Below The Knee Stenosis, by End User USD Million (2022-2027)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Below The Knee Stenosis: by Type USD Million (2016-2021)
  • Figure 5. Global Below The Knee Stenosis: by Application USD Million (2016-2021)
  • Figure 6. Global Below The Knee Stenosis: by End User USD Million (2016-2021)
  • Figure 7. South America Below The Knee Stenosis Share (%), by Country
  • Figure 8. Asia Pacific Below The Knee Stenosis Share (%), by Country
  • Figure 9. Europe Below The Knee Stenosis Share (%), by Country
  • Figure 10. MEA Below The Knee Stenosis Share (%), by Country
  • Figure 11. North America Below The Knee Stenosis Share (%), by Country
  • Figure 12. Global Below The Knee Stenosis share by Players 2021 (%)
  • Figure 13. Global Below The Knee Stenosis share by Players (Top 3) 2021(%)
  • Figure 14. Global Below The Knee Stenosis share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 18. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 19. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2021
  • Figure 20. Medtronic plc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic plc (United States) Revenue: by Geography 2021
  • Figure 22. Shockwave Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Shockwave Medical, Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 25. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 26. OrbusNeich Medical (Hong Kong) Revenue, Net Income and Gross profit
  • Figure 27. OrbusNeich Medical (Hong Kong) Revenue: by Geography 2021
  • Figure 28. Orchestra BioMed, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Orchestra BioMed, Inc. (United States) Revenue: by Geography 2021
  • Figure 30. Rex Medical, L.P. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Rex Medical, L.P. (United States) Revenue: by Geography 2021
  • Figure 32. Bbraun (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Bbraun (United Kingdom) Revenue: by Geography 2021
  • Figure 34. Rontis Corporation AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Rontis Corporation AG (Switzerland) Revenue: by Geography 2021
  • Figure 36. Global Below The Knee Stenosis: by Type USD Million (2022-2027)
  • Figure 37. Global Below The Knee Stenosis: by Application USD Million (2022-2027)
  • Figure 38. Global Below The Knee Stenosis: by End User USD Million (2022-2027)
  • Figure 39. South America Below The Knee Stenosis Share (%), by Country
  • Figure 40. Asia Pacific Below The Knee Stenosis Share (%), by Country
  • Figure 41. Europe Below The Knee Stenosis Share (%), by Country
  • Figure 42. MEA Below The Knee Stenosis Share (%), by Country
  • Figure 43. North America Below The Knee Stenosis Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boston Scientific Corporation (United States)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic plc (United States)
  • Shockwave Medical, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • OrbusNeich Medical (Hong Kong)
  • Orchestra BioMed, Inc. (United States)
  • Rex Medical, L.P. (United States)
  • Bbraun (United Kingdom)
  • Rontis Corporation AG (Switzerland)
Additional players considered in the study are as follows:
Meditek Systems (India) , Hexacath (France) , Vissco Rehabilitation Aids Pvt. Ltd. (India) , Essex Cardiology Group (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 155 Pages 93 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Boston Scientific Corporation (United States), Koninklijke Philips N.V. (Netherlands), Medtronic plc (United States), Shockwave Medical, Inc. (United States), Becton, Dickinson and Company (United States), OrbusNeich Medical (Hong Kong), Orchestra BioMed, Inc. (United States), Rex Medical, L.P. (United States), Bbraun (United Kingdom) and Rontis Corporation AG (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing R&D on in Healthcare industry " is seen as one of major influencing trends for Below The Knee Stenosis Market during projected period 2021-2027.
The Below The Knee Stenosis market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Below The Knee Stenosis Market Report?